LONDON, 13 January 2021 – Covington advised Sensyne Health plc, a UK clinical artificial intelligence company listed on the London AIM market, on its £27.5 million equity fundraising. The fundraise consisted of a placing with institutional investors, a subscription by directors and senior management, and an open offer to the company's existing shareholders.
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.
The UK and EU negotiators reached agreement on the future relationship just days before the end of the Brexit transition period, ending UK’s participation in the EU’s Single Market and Customs Union. The UK-EU Trade and Cooperation Agreement concluded on 24 December 2020, was ratified by the UK Parliament on 30 December, provisionally applicable since 1 January 2021, as agreed with the European Commission and EU Member States pending European Parliament consent and Council decision by end of February.